IRIS UniCatt

Cammarota, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.793
NA - Nord America 11.087
AS - Asia 9.255
SA - Sud America 2.170
AF - Africa 215
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 33
Totale 35.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.736
DE - Germania 5.346
SG - Singapore 4.300
CN - Cina 2.666
BR - Brasile 1.801
IT - Italia 1.671
SE - Svezia 1.573
UA - Ucraina 837
FR - Francia 700
GB - Regno Unito 667
IE - Irlanda 473
VN - Vietnam 432
PL - Polonia 392
IN - India 359
ID - Indonesia 342
FI - Finlandia 340
RU - Federazione Russa 259
TR - Turchia 194
CA - Canada 163
HK - Hong Kong 155
AR - Argentina 147
JP - Giappone 126
NL - Olanda 108
BD - Bangladesh 106
MX - Messico 106
IQ - Iraq 89
KR - Corea 89
BE - Belgio 85
ES - Italia 85
EC - Ecuador 53
ZA - Sudafrica 52
PK - Pakistan 51
AT - Austria 47
VE - Venezuela 42
CO - Colombia 41
CH - Svizzera 40
CZ - Repubblica Ceca 33
IR - Iran 33
UZ - Uzbekistan 32
SA - Arabia Saudita 31
AE - Emirati Arabi Uniti 29
IL - Israele 28
JO - Giordania 28
MA - Marocco 28
EU - Europa 27
AU - Australia 26
KE - Kenya 25
LT - Lituania 25
TN - Tunisia 25
CL - Cile 24
PY - Paraguay 21
EG - Egitto 17
KZ - Kazakistan 17
AZ - Azerbaigian 16
DZ - Algeria 15
RO - Romania 15
CI - Costa d'Avorio 14
PA - Panama 14
PT - Portogallo 14
JM - Giamaica 13
UY - Uruguay 13
BO - Bolivia 12
PE - Perù 12
TW - Taiwan 12
BH - Bahrain 11
CR - Costa Rica 11
LK - Sri Lanka 11
NP - Nepal 11
HR - Croazia 10
OM - Oman 10
DO - Repubblica Dominicana 9
HU - Ungheria 9
PH - Filippine 9
RS - Serbia 9
AL - Albania 8
GE - Georgia 8
LB - Libano 8
GR - Grecia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
ET - Etiopia 6
HN - Honduras 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
BG - Bulgaria 5
GT - Guatemala 5
KG - Kirghizistan 5
KW - Kuwait 5
MY - Malesia 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
BZ - Belize 4
CY - Cipro 4
GH - Ghana 4
LA - Repubblica Popolare Democratica del Laos 4
NG - Nigeria 4
NO - Norvegia 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
Totale 35.509
Salva come PNG Salva come JPEG
Città #
Singapore 1.835
Chandler 1.774
Ashburn 1.113
Jacksonville 485
Dublin 465
Beijing 458
San Mateo 383
Nürnberg 378
Ann Arbor 359
Hefei 327
Jakarta 314
Nanjing 300
Los Angeles 276
New York 276
Warsaw 275
Rome 274
Woodbridge 231
Boston 226
Wilmington 225
Milan 223
Munich 215
Cattolica 188
Dearborn 167
Marseille 166
Princeton 152
Ho Chi Minh City 151
São Paulo 145
Houston 142
Frankfurt am Main 140
Hong Kong 139
Moscow 137
Fairfield 136
Izmir 134
Seattle 133
Redwood City 124
Chicago 112
Nanchang 112
Dallas 109
Hanoi 103
Buffalo 101
Kent 89
Lawrence 89
Seoul 84
Tokyo 79
Helsinki 78
Boardman 77
Brussels 77
Kraków 75
Turku 74
Shanghai 73
Shenyang 73
Hangzhou 71
London 71
Fuzhou 68
The Dalles 66
Rio de Janeiro 63
Lancaster 59
Redmond 59
Bremen 57
Hebei 57
Santa Clara 57
Verona 55
Brooklyn 54
Mountain View 54
Nuremberg 54
Guangzhou 52
Leawood 52
Pune 49
Zhengzhou 49
Belo Horizonte 48
Kunming 47
Tianjin 47
Denver 44
Stockholm 44
University Park 44
Las Vegas 43
Phoenix 43
Changsha 42
Cambridge 40
Toronto 40
Baghdad 39
Düsseldorf 38
Norwalk 37
San Francisco 37
Fremont 36
North Bergen 35
Atlanta 33
Augusta 33
Jiaxing 33
Montreal 32
Johannesburg 31
Amsterdam 29
Falls Church 29
Amman 28
Curitiba 28
Dhaka 28
Manchester 28
Poplar 28
Chennai 27
Orem 26
Totale 16.035
Salva come PNG Salva come JPEG
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 490
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 412
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 407
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 406
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 339
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 295
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 264
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 247
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 242
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 238
Wheat desensitization treatment in patients with gluten sensitivity 234
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 233
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 233
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 228
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 223
-High prevalence of celiac disease in patients with lactose intolerance 213
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 209
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 207
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 203
The role of diet on gut microbiota composition 201
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 199
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 198
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 196
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 193
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 193
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 193
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 192
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 191
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 189
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 187
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 186
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 185
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 181
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 176
Fecal microbiota transplantation: Past, present and future perspectives 176
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 176
. Adverse reactions to food: allergies and intolerances. 175
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 171
Celiac disease: what's new about it? 170
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 168
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 168
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 167
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 165
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 165
(gc)Association of laryngeal cancer with previous gastric resection. 162
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 162
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 161
Can chronic gastritis cause increase of fecal calprotectin concentrations? 160
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 159
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 158
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 157
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 156
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 155
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 154
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 154
A) Association of laryngeal cancer with previous gastric resection 154
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 154
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 153
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 152
[Helicobacter pylori infection: from gastric to systemic disease] 151
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 149
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 148
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 147
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 145
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 145
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 144
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 144
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 143
Classification of malabsorption syndromes. 142
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 142
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 141
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 140
gc) Tired legs a gut diagnosis 140
Microscopic colitis 140
Faecal calprotectin concentrations in untreated coeliac patients 140
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 140
Gut microbiome, big data and machine learning to promote precision medicine for cancer 140
Levofloxacin based regimens for the eradication of Helicobacter pylori 139
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 139
gastroesophageal reflux disease: facts and uncertaines 139
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 139
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 139
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 138
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 138
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 138
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 137
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 137
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 136
Gluten-related Recurrent Peripheral Facial Palsy 135
(gc) Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study 135
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 135
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 134
Celiac disease and chronic urticaria resolution: a case report. 134
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 133
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 133
Moderately Severe Acute Pancreatitis Associated With Riluzole 133
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 132
Reflux symptoms in wind instrument players. 130
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 130
gc) Free Peritoneal Gas Accumulation Caused by Pneumatosis Coli After Diagnostic Gastrointestinal Endoscopy. 129
Totale 17.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.241 0 0 0 0 0 170 231 54 233 91 395 67
2021/20222.093 117 185 57 129 130 89 39 337 97 95 388 430
2022/20234.882 628 658 365 732 320 599 247 386 596 94 159 98
2023/20242.645 133 704 90 173 119 318 175 95 70 156 322 290
2024/20255.946 148 198 470 167 456 189 165 326 831 588 1.257 1.151
2025/20268.669 2.423 534 951 1.672 2.551 538 0 0 0 0 0 0
Totale 35.970